AstraZeneca, Teva Unit Finalize $54M Deal In Medicaid Row
AstraZeneca LP and a Teva Pharmaceutical Industries Ltd. subsidiary have finalized a $54 million deal with state governments, settling claims that they overcharged state Medicaid programs for their drugs, New York's...To view the full article, register now.
Already a subscriber? Click here to view full article